

Contractor Name
HealthNow UMD
Contract Number
00801
Contractor Type
Carrier
LCD Database ID Number
L3573
LCD Title
Abdominal Retroperitoneal Ultrasound
Contractor's Determination Number
R-97-1 (6A) End dated
AMA CPT Copyright Statement
CPT codes, descriptions, and other data only are copyright 2007 American
Medical Association (or such other data of publication of CPT). All
Rights Reserved. Applicable FARS/DFARS clauses apply. Current Dental
Terminology (CDT) (including procedure codes, nomenclature, descriptors
and other data contained therein) is copyright by the American Dental
Association. (C) 2002, 2004 American Dental Association. All rights
reserved. Applicable FARS/DFARS apply.
CMS National Coverage Policy
- Title XVIII of the Social Security Act, Section 1862 (a)(7)
This section excludes routine physical examinations.
- Title XVIII of the Social Security Act, Section 1862 (a)(1)(A)
This section allows coverage and payment for only those services
considered medically reasonable and necessary.
- Title XVIII of the Social Security Act, Section 1833 (e)
This section prohibits Medicare payment for any claim which lacks the
necessary information to process the claim.
- CMS Manual System, Pub100-4, Medicare Claims Processing Manual,
Chapter 13, Section 20 and 90.
These sections address payment for radiology services and for portable
x-ray services.
Primary Geographic Jurisdiction
Oversight Region
Region II
CMS Consortium
Northeast
Original Determination Effective Date
For services performed on or after 12/01/1997
Original Determination Ending Date
05/15/2008
Revision Effective Date
For services performed on or after 10/01/2007
Revision Ending Date
05/15/2008
Indications and Limitations of Coverage and/or Medical Necessity
Retroperitoneal ultrasound studies represent the ultrasonic imaging of
retroperitoneal organs. The state of the art of ultrasound demands a high
degree of manual dexterity, hand-eye coordination, a thorough
understanding of anatomy, physiology, pathology, patient contours
capabilities and limitations, and transducer characteristics.
A complete study visualizes all the structures or organs within the anatomic description of that study. A limited study involves a single quadrant or a single diagnostic problem, or an evaluation of an organ of interest. Limited studies may be used to re-evaluate a problem after the initial study in order to clarify a finding on the initial study.
1. Abdominal aorta and renal arteries--Aneurysms of abdominal aorta are
usually diagnosed by physical exam or coincidentally by other x-ray
studies. Ultrasound is very accurate for aortic measurement and may
be used to follow patients with aneurysms.
2. Inferior Vena Cava--Ultrasound is useful in detection of invasion by
adjacent tumors and identification of obstruction levels. It is also
of value in the follow up of vena cava filter localization. It may
be of some use to identify the level of proliferative clot above the
inguinal ligament.
3. Kidneys, ureter, and bladder:
a. Kidneys:
The medical necessity of IVP and ultrasound have broad
overlapping indications and should be utilized judiciously at the
same encounter only if proper diagnostic dilemma exists.
Ultrasound is useful to preclude obstruction in symptomatic
patients and for guidance of percutaneous nephrostomy tubes. It
also may confirm scarred or small kidneys in chronic renal
cortical disease, but is of no use in detecting early or mild
cortical disorders or to categorize specific types of cortical
diseases.
Ultrasound is useful in detecting and following of renal cysts
and localizing solid masses. Benign renal cysts should be
followed if they become symptomatic. Otherwise, they should be
considered relatively harmless.
b. Ureter:
Ureters are usually not well visualized by ultrasound, especially
in their mid portions; but ultrasound may rarely be helpful to
confirm the presence of dilatation, filling defects, or a mass in
its most proximal or distal portions. Ultrasound also has a role
in vesicle ureteral reflex.
c. Bladder:
Tumors of the bladder are most efficiently followed by cystoscopy
and urography. However, ultrasound is useful in following
intraluminal bladder tumor with or without extraluminal
extension; including evaluation of bladder wall thickness and
irregularity.
4. Renal Transplants:
Ultrasound is indicated to detect urinary obstruction, fluid
collections, vascular complications of renal transplants and is
considered a primary tool in this endeavor. Utilization frequency of
this modality for renal transplants is dictated by the presence and
absence of signs and symptoms.
5. Adenopathy--CT is far more accurate than ultrasound in detecting and
delineating adenopathy. Therefore, ultrasound should be of secondary
importance and rarely utilized in the detection or follow up of nodal
disease.
6. Prostate:
Evaluation of the prostate is primarily done transrectally, by
ultrasound
7. Adrenal Gland:
Ultrasound is of little value since CT is considered more accurate.
8. Connective Tissue Tumors:
These are usually detected by physical exam or CT. Ultrasound is of
limited value.
Coverage Topic
CPT/HCPCS Codes
76770 Ultrasound, retroperitoneal (e.g., renal, aorta, nodes), real time with image documentation; complete
76775 ; limited
Does the CPT 30% Coding Rule Apply?
No
ICD-9-CM Codes That Support Medical Necessity
TRUNCATED DIAGNOSIS CODES ARE NOT ACCEPTABLE.
ICD-9-CM code listings may cover a range and include truncated codes. It is the provider's responsibility to avoid truncated codes by selecting a code(s) carried out to the highest level of specificity and selected from the ICD-9-CM book appropriate to the year in which the service was performed.
It is not enough to link the procedure code to a correct, payable ICD-9-CM code. The diagnosis or clinical signs/symptoms must be present for the procedure to be paid.
Further, these ICD-9-CM codes can be used only with the conditions listed in the "Indications" and "Limitations" section of this determination.
158.0-158.9 Malignant neoplasm of retroperitoneum - Malignant neoplasm of peritoneum unspecified
189.0-189.9 Malignant neoplasm of kidney except pelvis - Malignant neoplasm of urinary organ site unspecified
197.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
200.00-200.88 Reticulosarcoma unspecified site - other naked variants of lymphosarcoma and reticulosarcoma involving lymph nodes of multiple sites
201.00-201.98 Hodgkin's paragranuloma unspecified site - Hodgkin's disease unspecified type involving lymph nodes of multiple sites
202.00-202.98 Nodular lymphoma unspecified site - other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving lymph nodes of multiple sites.
223.0-223.9 Benign neoplasm of kidney except pelvis - benign neoplasm of urinary organ site unspecified
403.00-403.91 Hypertensive chronic kidney disease,malignant, with chronic kidney disease Stage I through Stage IV, or unspecified-hypertensive chronic kidney disease, unspecified, with chronic kidney disease Stage V or end stage renal disease
441.02 Aortic aneurysm and dissection/abdominal
441.03 Aortic aneurysm and dissection/thoracoabdominal
441.3 Abdominal aneurysm, ruptured
441.4 Abdominal aneurysm without mention of rupture
441.5 Aortic aneurysm of unspecified site, ruptured
442.1 Other aneurysm of renal artery
453.3 Other venous embolism and thrombosis of renal vein
459.2 Compression of vein
580.0-580.9 Acute glomerulonephritis with lesion of proliferative glomeruloneuritis - acute glomerulonephritis with unspecified pathological lesion in kidney
581.0-581.9 Nephrotic syndrome with lesion of proliferative glomerulonephritis-nephrotic syndrome with unspecified pathological lesion in kidney
582.0-582.9 Chronic glomerulonephritis with lesion of proliferative glomerulonephritis - chronic glomerulonephritis with unspecified pathological lesion in kidney
583.0-583.9 Nephritis and nephropathy not specified as acute or chronic with lesion of proliferative glomeruloneuritis- nephritis and nephropathy not specifed as acute or chronic with unspecified pathological lesion in kidney
584.5-584.9 Acute renal failure with lesion of tubular necrosis -acute renal failure unspecified
585.1 Chronic kidney disease, Stage I
585.2 Chronic kidney disease, Stage II (mild)
585.3 Chronic kidney disease, Stage III (moderate)
585.4 Chronic kidney disease, Stage IV (severe)
585.5 Chronic kidney disease, Stage V
585.6 End stage renal disease
585.9 Chronic kidney dissease, unspecified
586 Renal failure, unspecified
587 Renal sclerosis, unspecified
589.0-589.9 Unilateral small kidney-small kidney unspecified
590.00-590.9 Chronic pyelonephritis without lesion of renal medullary necrosis-infection of kidney unspecified
591 Hydronephrosis
592.0 Calculus of kidney
593.1 Hypertrophy of kidney
593.2 Cyst of kidney, acquired
593.9 Unspecified disorder of kidney and ureter
599.0 Urinary tract infection, site not specified
599.60 Urinary obstruction, unspecified
599.69 Urinary obstruction, not elsewhere classified
599.7 Hematuria
785.9 Other symptoms involving cardiovascular system
788.5 Oliguria and anuria
789.30-789.39 Abdominal or pelvic swelling mass or lump unspecified site-abdominal or pelvic swelling mass or lump other specified site
794.4 Nonspecific abnormal results of function studies/kidney
996.1 Mechanical complication of other vascular device, implant, and graft
996.81 Complications of transplanted kidney
V71.1 Observation for suspected malignant neoplasm
ICD-9-CM Codes That DO NOT Support Medical Necessity:
Use of any ICD-9-CM code not listed in the "ICD-9-CM Codes That Support
Medical Necessity" section of this policy will be denied
Documentation Requirements
1. Each claim must be submitted with ICD-9-CM codes that reflect the
condition of the patient, and indicate the reason(s) for which the
service was performed. Claims submitted without ICD-9-CM codes will
be returned.
2. All studies must have an interpretation on file and should be
available for review. The report should give the indication for the
study.
3. Hard copy and/or video images should also be on file and be available
for review.
4. For studies done at the request of a referring physician, the
requisition should be kept on file as well.
5. For studies done where the referring physician is also the physician
completing the study, the office records should reflect a clear need
for these studies.
6. Documentation must be available to Medicare upon request.Sources of Information and Basis for Decision
Advisory Committee Meeting Notes
- This policy is being adopted from Empire Medicare Services' policy
that was presented to the CAC on June 11, 1997. Changes to this
policy that was originally presented to the CAC on June 11, 1997, by
Empire Medicare Services are the direct results from comments that
were received from James Chang, M.D., alternate representative for the
New York State Radiological Society.
- This policy does not reflect the sole opinion of the contractor or
Contractor Medical Director. Although the final decision rests with
the carrier, this policy was developed in cooperation with advisory
groups, which includes representatives from the New York State
Radiological Society, Inc. and the Medical Society of the State of New
York.
Start Date of Comment Period
End Date of Comment Period
07/27/1997
Start Date of Notice Period
01/31/2008
Revision History Number
5
Revision History Explanation
This LCD is end dated because it is no longer an effective education tool.
Revision #5: Update of ICD-9CM descriptions completed for 2007.
Revision #4: Removed truncated ICD-9CM codes 585 and 599.6. Revised the description of code 76770 effective January 1, 2007.
Revision #3: This LCD is revised to include 785.9 as payable. No changes made to Coding Guidelines article
Revision #2: Updated policy to new format, revised description for code 76770/76775 and added Benefit Category and Coverage Topics.
Revision #1: Deleted item 3a, paragraph 4 from Indications & Limitations. Added 599.7, Hematuria, to the covered list of ICD-9CM codes.
This LCD was converted from an LMRP on 9/24/2004
|
© 1998 - 2008 Upstate Medicare Division. All rights reserved.